Post-Transplant Bone Disease in Kidney Transplant Recipients: Diagnosis and Management
International Journal of Molecular Sciences · 03.02.2024 · 25 (3) · 1859
DOI: 10.3390/ijms25031859 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.02.2024. Verfasst von Jia Wei Teh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Galway University Hospital, H91 YR71 Galway, Ireland. Hauptthemen laut MEDLINE: Kidney Transplantation, Chronic Kidney Disease-Mineral and Bone Disorder, Osteoporosis, Fractures, Bone. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kidney transplantation is the preferred gold standard modality of treatment for kidney failure. Bone disease after kidney transplantation is highly prevalent in patients living with a kidney transplant and is associated with high rates of hip fractures. Fractures are associated with increased healthcare costs, morbidity and mortality. Post-transplant bone disease (PTBD) includes renal osteodystrophy, osteoporosis, osteonecrosis and bone fractures. PTBD is complex as it encompasses pre-existing chronic kidney disease–mineral bone disease and compounding factors after transplantation, including the use of immunosuppression and the development of de novo bone disease. After transplantation, the persistence of secondary and tertiary hyperparathyroidism, renal osteodystrophy, relative vitamin D deficiency and high levels of fibroblast growth factor-23 contribute to post-transplant bone disease. Risk assessment includes identifying both general risk factors and kidney-specific risk factors. Diagnosis is complex as the gold standard bone biopsy with double-tetracycline labelling to diagnose the PTBD subtype is not always readily available. Therefore, alternative diagnostic tools may be used to aid its diagnosis. Both non-pharmacological and pharmacological therapy can be employed to treat PTBD. In this review, we will discuss pathophysiology, risk assessment, diagnosis and management strategies to manage PTBD after kidney transplantation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, Galway University Hospital, H91 YR71 Galway, Ireland.
- Department of Rheumatology, Galway University Hospital, H91 YR71 Galway, Ireland.
- School of Medicine, University of Galway, H91 TK33 Galway, Ireland.
ORCID-Profile: Jia Wei Teh
Zitieren
APA
Teh, J. W., Mac Gearailt, C., & Lappin, D. W. P. (2024). Post-Transplant Bone Disease in Kidney Transplant Recipients: Diagnosis and Management. International Journal of Molecular Sciences, 25(3), 1859. https://doi.org/10.3390/ijms25031859
Vancouver
Teh JW, Mac Gearailt C, Lappin DWP. Post-Transplant Bone Disease in Kidney Transplant Recipients: Diagnosis and Management. International Journal of Molecular Sciences. 2024;25(3):1859. doi:10.3390/ijms25031859
BibTeX
@article{Teh2024,
author = {Teh, Jia Wei and Mac Gearailt, Conall and Lappin, David W P},
title = {Post-Transplant Bone Disease in Kidney Transplant Recipients: Diagnosis and Management},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {3},
pages = {1859},
doi = {10.3390/ijms25031859}
}
EUVIMED